Can a simple check of nutrition and muscle predict lung surgery outcomes?
NCT ID NCT07500376
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study follows 142 adults having lung cancer surgery to see if measuring nutrition and muscle loss can help predict complications, hospital stay, and survival. Participants get blood tests, CT scans, and ultrasound before surgery. The goal is to create a better risk score to guide personalized care, like nutrition support before surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 142 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients undergoing anatomical lung resection (lobectomy or segmentectomy) for primary lung cancer at a tertiary thoracic surgery center will be included. All participants will be prospectively enrolled and evaluated preoperatively for nutritional status and sarcopenia using clinical, biochemical, and imaging-based assessments.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * Patients undergoing anatomical lung resection (lobectomy or segmentectomy) for primary lung cancer * Availability of preoperative thoracic computed tomography (CT) within 30 days before surgery * Completion of preoperative nutritional assessment and ultrasonographic muscle measurements * Ability to provide written informed consent Exclusion Criteria: * Receipt of neoadjuvant chemotherapy, immunotherapy, or radiotherapy * Emergency surgery * Pneumonectomy * Combined resection of another organ during the same procedure * Inadequate or non-evaluable imaging or measurement data * Immunosuppressive therapy or presence of advanced/metastatic disease * Significant thoracic deformity or prior conditions interfering with muscle measurements * Refusal or inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer (non-small cell) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ondokuz Mayis University Faculty of Medicine, Department of Thoracic Surgery
RECRUITINGSamsun, Samsun, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple checklist help surgeons remove every last cancer cell?
- Muscle loss may predict who struggles after cancer surgery
- Can a nutritional shake keep older adults strong and sharp?
- Could a medication side effect score predict falls in older adults?
- Can Cord-Tissue stem cells rebuild aging muscles?
- Scientists probe a muscle protein that may hold clues to Age-Related weakness